6.95MMarket Cap-337P/E (TTM)
0.5690High0.5401Low27.55KVolume0.5600Open0.5600Pre Close15.31KTurnover0.29%Turnover RatioLossP/E (Static)12.42MShares2.450052wk High0.84P/B5.36MFloat Cap0.405352wk Low--Dividend TTM9.57MShs Float116.9000Historical High--Div YieldTTM5.16%Amplitude0.4053Historical Low0.5550Avg Price1Lot Size
ABVC BioPharma Stock Forum
ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners
ABVC BioPharma has received an additional $50,000 in licensing fees from AiBtl BioPharma Inc., bringing the total payments from strategic partners to $346,000. This payment is part of a broader agreement related to ABVC's psychiatric disorder pipeline, which includes treatments for Major Depressive Disorder (MDD) and Attention Deficit ...
ABVC Biopharma- Got Written Notification From Nasdaq, Indicating Co Regained Compliance With Listing Rules 5635(a)(1) and 5635(a)(2)
- Earnings Per Share (EPS): Demonstrated a remarkable year-over-year improvement of approximately 86.8%, with EPS improving to -$0.09 in Q2 2024 from -$0.68 in the same period last year. This significant progress reflects our successful efforts in managing operational expenses and capitalizing on milestone payment revenue from licensing agreements.
- Revenue Growth: Revenue increased to $117,142 in Q2 2024, a substantial rise from $6,109...
$Bright Minds Biosciences (DRUG.US)$ $ABVC BioPharma (ABVC.US)$ $SAI TECH Global (SAI.US)$ $Addentax (ATXG.US)$ $Chuy's Holdings (CHUY.US)$
ABVC Biopharma Inc - Collaboration Between ABVC and Oncox Biopharma, ABVC Expecting Aggregate Income of $13.75 Mln and Royalties of up to $12.50 Mln
Larger Image: tradingview.com...
$ABVC BioPharma (ABVC.US)$
📊⚡️📊
No comment yet